• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Deca-Medics fights for cash to support unapproved product

Deca-Medics fights for cash to support unapproved product

October 22, 2010 By MedCity News

MedCity News logo

Performing cardiopulmonary resuscitation CPR is tiring.

After a few minutes, the effectiveness of CPR typically drops substantially because even trained professionals don’t have the muscular endurance to generate adequate force for more than a minute or two of intense chest compressions.

That’s the problem for which Columbus, Ohio-based Deca-Medics Inc. exists to solve.

The company developed a CPR device it calls the LifeBelt, which is engineered to reduce the amount of force required to perform chest compressions by half, and promises to help users more accurately gauge the depth of those compressions.

“It’s just taking the basic concept of doing chest compressions and making it easier for the individual who’s providing it, which should lead to better outcomes,” said CEO Thom Lach.

It’s been a long, hard slog for the company, which was founded in 1994 and raised $2.5 million, including a grant from the Cleveland Clinic-led Global Cardiovascular Innovation Center, yet still doesn’t have a product on the market. Credit Lach for persistence when many less-hardy entrepreneurs would’ve given up.

Lach’s endurance likely stems from his father Ralph, a cardiologist who in 1980 applied for a patent on a device that used a band to help perform CPR and long dreamed of getting such a device to market. Deca-Medics has six patents on its device.

Now, Lach is looking for $500,000 more to sustain the company during the often-bumpy process of obtaining regulatory approval to sell the device from the Food & Drug Administration.

“Trying to raise money without an approved product is an uphill battle, but this is something I believe in,” he said.

Those fundraising efforts may have received an unexpected boost from the American Heart Association last week. The association released new CPR guidelines that place greater emphasis on chest compressions. The new guidelines were inspired in part by recent research that indicates a compression-only approach is as good or better than compression plus mouth-to-mouth resuscitation.

From Lach’s perspective, the new guidelines can be viewed only as a positive for Deca-Medics.

“The new guidelines translate into faster, deeper compressions, both of which increase the fatigue, and subsequently the quality of each compression…. [That] almost dictates the need for some form of assist device to offset the increased physical demands,” he said.

Lach isn’t the only one who’s had the idea for a device that makes compressions easier. Several companies, including device giant Medtronic Inc., (NYSE:MDT) have introduced automated electronic compression systems. That may have scared off some potential Deca-Medics investors.

However, Lach says the competitors’ automated devices are more clunky and expensive than Deca-Medics’ manual LifeBelt — and they require batteries.

As usual, the market will decide which is better.

Filed Under: Uncategorized

More recent news

  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out
  • Former Masimo COO is joining BD to run Connected Care

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy